CDLX - Cardlytics Inc Stock Price, Fair Value and News

14.58USD-0.83 (-5.39%)Market Closed

Market Summary

USD14.58-0.83

Market Closed

-5.39%

CDLX Alerts

3 major insider sales recently.

CDLX Stock Price

View Fullscreen

CDLX RSI Chart

CDLX Valuation

Market Cap

711.3M

Price/Earnings (Trailing)

-4.12

Price/Sales (Trailing)

2.28

EV/EBITDA

-5.62

Price/Free Cashflow

-81.79

CDLX Price/Sales (Trailing)

CDLX Profitability

EBT Margin

-55.23%

Return on Equity

-86.67%

Return on Assets

-30.33%

Free Cashflow Yield

-1.22%

CDLX Fundamentals

CDLX Revenue

Revenue (TTM)

312.5M

Rev. Growth (Yr)

5.09%

Rev. Growth (Qtr)

-24.18%

CDLX Earnings

Earnings (TTM)

-172.6M

Earnings Growth (Yr)

-278.39%

Earnings Growth (Qtr)

75.93%

Breaking Down CDLX Revenue

Last 7 days

12.2%

Last 30 days

4.1%

Last 90 days

131.1%

Trailing 12 Months

153.6%

How does CDLX drawdown profile look like?

CDLX Financial Health

Current Ratio

2.13

Debt/Equity

1.14

Debt/Cashflow

-0.03

CDLX Investor Care

Shares Dilution (1Y)

43.87%

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	312.5M	0	0	0
2023	294.9M	296.2M	302.5M	309.2M
2022	281.8M	298.4M	306.1M	298.5M
2021	194.6M	225.2M	244.1M	267.1M
2020	220.0M	199.4M	189.1M	186.9M
2019	154.0M	167.1M	189.0M	210.4M
2018	136.2M	139.0M	142.1M	150.7M
2017	117.2M	121.6M	126.0M	130.4M
2016	0	0	0	112.8M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Cardlytics Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 24, 2024	gupta amit	sold	-278,885	11.91	-23,416	chief operating officer
Apr 23, 2024	lynton nicholas hollmeyer	sold	-3,521	12.758	-276	chief legal & privacy officer
Apr 23, 2024	gupta amit	acquired	-	-	43,750	chief operating officer
Apr 22, 2024	lynton nicholas hollmeyer	acquired	-	-	682	chief legal & privacy officer
Apr 02, 2024	temsamani karim saad	sold	-445,801	13.69	-32,564	chief executive officer
Apr 02, 2024	lynton nicholas hollmeyer	sold	-170,620	13.6934	-12,460	chief legal & privacy officer
Apr 01, 2024	lynton nicholas hollmeyer	acquired	-	-	27,966	chief legal & privacy officer
Apr 01, 2024	sosin clifford	sold	-	-	-237,563	-
Apr 01, 2024	temsamani karim saad	sold	-2,219	14.41	-154	chief executive officer
Apr 01, 2024	temsamani karim saad	acquired	-	-	50,000	chief executive officer

Which funds bought or sold CDLX recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 07, 2024	NEW YORK STATE COMMON RETIREMENT FUND	reduced	-2.22	37,000	105,000	-%
May 07, 2024	ClariVest Asset Management LLC	new	-	707,112	707,112	0.07%
May 07, 2024	Susquehanna Portfolio Strategies, LLC	sold off	-100	-534,990	-	-%
May 07, 2024	Headlands Technologies LLC	added	452	7,233	8,172	-%
May 07, 2024	Concurrent Investment Advisors, LLC	unchanged	-	69,638	191,109	0.01%
May 07, 2024	SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC	added	13.85	201,840	456,957	0.02%
May 07, 2024	SUSQUEHANNA INTERNATIONAL GROUP, LLP	added	234	3,270,840	4,037,290	-%
May 06, 2024	BROOKTREE CAPITAL MANAGEMENT	added	17.95	928,553	2,013,680	1.55%
May 06, 2024	Parallel Advisors, LLC	sold off	-100	-249	-	-%
May 06, 2024	Jefferies Financial Group Inc.	reduced	-27.26	-156,984	107,297	-%

Are Funds Buying or Selling CDLX?

Are funds buying CDLX calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own CDLX

No. of Funds

CDLX Alerts

3 major insider sales recently.

Unveiling Cardlytics Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Mar 29, 2024	cas investment partners, llc	14.4%	6,373,676	SC 13D/A
Mar 18, 2024	cas investment partners, llc	13.7%	6,023,676	SC 13D/A
Feb 14, 2024	683 capital management, llc	4.6%	1,758,462	SC 13G/A
Feb 13, 2024	vanguard group inc	5.49%	2,153,790	SC 13G/A
Jan 26, 2024	blackrock inc.	7.4%	2,912,025	SC 13G/A
Sep 19, 2023	cas investment partners, llc	14.4%	5,416,116	SC 13D/A
Jun 23, 2023	cas investment partners, llc	16.0%	5,416,116	SC 13D
Feb 15, 2023	683 capital management, llc	5.7%	1,883,020	SC 13G/A
Feb 14, 2023	cas investment partners, llc	16.3%	5,416,116	SC 13G/A
Feb 09, 2023	vanguard group inc	7.21%	2,392,757	SC 13G/A

Recent SEC filings of Cardlytics Inc

View All Filings

Date Filed	Form Type	Document
May 08, 2024	10-Q	Quarterly Report
May 08, 2024	8-K	Current Report
Apr 24, 2024	144	Notice of Insider Sale Intent
Apr 24, 2024	4	Insider Trading
Apr 23, 2024	144	Notice of Insider Sale Intent
Apr 23, 2024	4	Insider Trading
Apr 12, 2024	ARS	ARS
Apr 12, 2024	DEF 14A	DEF 14A
Apr 12, 2024	DEFA14A	DEFA14A
Apr 09, 2024	3	Insider Trading

Peers (Alternatives to Cardlytics Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
OMC	18.8B	14.9B	2.19%	3.76%	12.7	1.27	3.89%	8.20%
IPG	11.7B	10.9B	-1.62%	-13.62%	10.79	1.08	-0.15%	19.70%
MID-CAP
ZD	2.5B	1.4B	-5.12%	-16.10%	60.51	1.84	-1.94%	-34.90%
CMPR	2.2B	3.2B	-13.52%	91.32%	24.64	0.66	7.78%	135.65%
SMALL-CAP
CRTO	2.1B	2.0B	6.42%	17.52%	29.01	1.08	0.16%	407.18%
CDLX	711.3M	312.5M	4.07%	153.57%	-4.12	2.28	5.95%	64.39%
DLPN	20.7M	43.1M	-7.50%	-49.77%	-0.85	0.48	6.46%	-410.38%
CNET	5.9M	29.7M	-21.90%	-47.77%	-0.81	0.24	-13.28%	-56.29%

Cardlytics Inc News

Latest updates

Cardlytics Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-24.2%	67,608,000	89,167,000	79,005,000	76,701,000	64,331,000	82,503,000	72,706,000	75,405,000	67,928,000	90,049,000	64,984,000	58,853,000	53,230,000	67,082,000	46,079,000	28,222,000	45,509,000	69,293,000	56,419,000	48,730,000	35,988,000
Costs and Expenses	-52.9%	90,434,000	192,089,000	99,657,000	101,024,000	52,104,000	465,138,000	61,186,000	197,724,000	32,272,000	106,458,000	104,777,000	103,081,000	75,399,000	73,199,000	62,218,000	47,960,000	57,438,000	68,037,000	63,017,000	54,212,000	42,489,000
S&GA Expenses	0.0%	14,118,000	14,111,000	14,161,000	15,205,000	13,948,000	16,825,000	18,289,000	21,983,000	17,648,000	18,998,000	16,733,000	17,063,000	13,202,000	12,502,000	11,432,000	10,405,000	10,968,000	12,370,000	11,074,000	11,047,000	9,337,000
R&D Expenses	4.3%	13,048,000	12,511,000	12,430,000	14,847,000	11,564,000	14,801,000	13,762,000	13,581,000	12,291,000	11,811,000	11,141,000	8,934,000	6,218,000	5,088,000	4,627,000	3,966,000	3,851,000	2,958,000	3,018,000	2,782,000	2,941,000
EBITDA Margin	-33.9%	-0.48	-0.36	-1.28	-1.19	-1.54	-1.45	-0.24	-0.43	-0.19	-0.45	-0.47	-0.39	-	-	-	-	-	-	-	-	-
Interest Expenses	2.4%	-819,000	-839,000	-915,000	-574,000	-8,000	-150,000	-580,000	-879,000	-947,000	-3,247,000	-3,193,000	-3,078,000	-3,045,000	-3,039,000	-283,000	-10,000	284,000	312,000	-218,000	-338,000	-304,000
Income Taxes	-	-	-	-	-	-	-	-	-1,446,000	-	-7,864,000	-	-	-	-	-	-	-	-	-	-	-
Earnings Before Taxes	75.9%	-24,275,000	-100,836,000	-23,966,000	-23,508,000	13,608,000	-378,279,000	6,267,000	-127,736,000	33,038,000	-19,699,000	-44,529,000	-47,306,000	-24,895,000	-6,777,000	-15,356,000	-19,758,000	-13,531,000	3,427,000	-7,747,000	-6,510,000	-6,314,000
EBT Margin	-26.8%	-0.55	-0.44	-1.36	-1.29	-1.65	-1.56	-0.35	-0.53	-0.28	-0.51	-0.51	-0.42	-	-	-	-	-	-	-	-	-
Net Income	75.9%	-24,275,000	-100,836,000	-23,966,000	-23,508,000	13,608,000	-378,279,000	6,267,000	-126,290,000	33,038,000	-11,835,000	-44,529,000	-47,306,000	-24,895,000	-6,777,000	-15,356,000	-19,758,000	-13,531,000	3,427,000	-7,747,000	-6,510,000	-6,314,000
Net Income Margin	-26.8%	-0.55	-0.44	-1.36	-1.29	-1.64	-1.56	-0.32	-0.50	-0.25	-0.48	-0.51	-0.42	-	-	-	-	-	-	-	-	-
Free Cashflow	-786.8%	-18,268,000	2,660,000	1,143,000	5,769,000	-10,424,000	-13,182,000	-14,635,000	-7,170,000	-20,088,000	-1,518,000	-10,813,000	-15,391,000	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-0.9%	569	574	635	633	685	691	1,066	1,090	1,231	1,264	1,225	1,233	1,023	423	389	183	206	224	193	144	146
Current Assets	-2.5%	218	224	206	202	246	250	249	264	319	359	336	338	703	386	354	146	170	196	166	115	117
Cash Equivalents	6.5%	98.00	92.00	90.00	92.00	139	122	139	157	208	233	237	251	614	293	288	98.00	102	105	95.00	32.00	36.00
Net PPE	-12.5%	3.00	3.00	3.00	3.00	5.00	6.00	7.00	9.00	10.00	11.00	12.00	13.00	14.00	14.00	13.00	13.00	13.00	14.00	12.00	12.00	11.00
Goodwill	0%	277	277	353	353	353	353	666	666	748	743	719	718	203	-	-	-	-	-	-	-	-
Liabilities	-15.8%	370	439	410	397	452	480	486	525	520	573	536	518	278	265	239	53.00	68.00	81.00	-	-	-
Current Liabilities	-40.1%	103	171	179	168	191	249	255	294	247	327	274	263	92.00	81.00	58.00	42.00	58.00	78.00	63.00	57.00	50.00
Short Term Borrowings	-	-	-	30.00	30.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt	0.2%	228	228	-	-	-	226	-	-	-	184	-	-	-	174	-	-	0.00	0.00	0.00	37.00	47.00
LT Debt, Current	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
LT Debt, Non Current	-100.0%	-	228	-	-	-	226	-	-	-	184	-	-	-	174	-	-	0.00	0.00	0.00	37.00	47.00
Shareholder's Equity	47.7%	199	135	225	236	232	212	581	564	712	691	689	714	745	157	150	130	138	143	127	47.00	47.00
Retained Earnings	-2.2%	-1,135	-1,111	-1,010	-986	-962	-976	-598	-604	-478	-522	-510	-466	-418	-394	-387	-371	-352	-338	-342	-334	-327
Additional Paid-In Capital	7.1%	1,332	1,244	1,230	1,220	1,191	1,183	1,169	1,163	1,188	1,213	1,199	1,181	1,164	551	536	500	488	481	467	379	373
Shares Outstanding	8.9%	40.00	36.00	36.00	34.00	34.00	33.00	33.00	34.00	34.00	32.00	33.00	31.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	233	-	-	-	713	-	-	-	4,100	-	-	-	-	-	-	-	1,800	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-700.4%	-17,617	2,934	1,194	5,751	-10,064	-13,101	-14,434	-6,678	-19,691	-555	-10,458	-14,978	-12,532	5,616	-5,570	-4,238	-3,406	4,100	10,326	-1,486	-1,483
Share Based Compensation	-0.4%	10,985	11,024	10,249	11,739	7,968	12,492	5,767	12,842	13,585	12,849	16,830	13,337	7,248	7,585	11,578	9,108	4,125	3,585	7,486	3,072	1,708
Cashflow From Investing	-247.3%	-4,747	-1,367	-3,146	-2,747	-2,802	-3,153	-3,304	-4,269	-5,034	-3,414	-2,871	-348,448	-151,962	-3,857	-2,873	-1,950	-1,437	-4,609	-1,248	-3,182	-1,981
Cashflow From Financing	58902.1%	28,321	48.00	21.00	-50,076	29,981	-179	-6.00	-39,984	182	225	370	738	484,665	3,417	197,602	2,272	3,139	9,130	43,939	-9,052	162
Buy Backs	-	-	-	-	-	-	-	-	40,000	173	-	12.00	904	-	-	-	-	-	-	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

CDLX Income Statement

2023-12-31

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Revenue	$ 309,204	$ 298,542	$ 267,116
Costs and expenses:
Partner Share and other third-party costs	150,578	155,507	141,273
Delivery costs	28,248	30,403	22,503
Sales and marketing expense	57,425	74,745	65,996
Research and development expense	51,352	54,435	38,104
General and administration expense	58,810	81,446	66,222
Acquisition, integration and divestiture (benefits) costs	(6,313)	(2,874)	24,372
Change in fair value of contingent consideration	1,246	(128,174)	1,374
Impairment of goodwill and intangible assets	70,518	453,288	0
Loss on divestiture	6,550	0	0
Depreciation and amortization expense	26,460	37,544	29,871
Total costs and expenses	444,874	756,320	389,715
Operating loss	(135,670)	(457,778)	(122,599)
Other income (expense):
Interest expense, net	(2,336)	(2,556)	(12,563)
Other Nonoperating Income (Expense)	3,304	(6,376)	(1,267)
Total other income (expense)	968	(8,932)	(13,830)
Loss before income taxes	(134,702)	(466,710)	(136,429)
Income tax benefit	0	1,446	7,864
Net Loss	(134,702)	(465,264)	(128,565)
Net Loss attributable to common stockholders	$ (134,702)	$ (465,264)	$ (128,565)
Net loss per share attributable to common stockholders, basic (in shares)	$ (3.69)	$ (13.92)	$ (3.99)
Weighted-average common shares outstanding, basic (in shares)	36,488,000	33,419,000	32,202,000

CDLX Balance Sheet

2023-12-31

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 91,830	$ 121,905
Restricted cash	0	80
Accounts receivable and contract assets, net	120,622	115,609
Other receivables	5,379	4,470
Prepaid expenses and other assets	6,097	7,978
Total current assets	223,928	250,042
Long-term assets:
Property and equipment, net	3,323	5,916
Right-of-use assets under operating leases, net	7,310	6,571
Intangible assets, net	35,003	53,475
Goodwill	277,202	352,721
Capitalized software development costs, net	24,643	19,925
Deferred implementation costs, net	0	0
Other long-term assets, net	2,735	2,586
Total assets	574,144	691,236
Current liabilities:
Accounts payable	4,425	3,765
Accrued liabilities:
Accrued compensation	11,662	10,486
Accrued expenses	9,587	21,335
Partner Share liability	48,867	48,593
Consumer Incentive liability	52,678	53,983
Deferred revenue	2,405	1,751
Current operating lease liabilities	2,127	4,910
Current contingent consideration	(39,398)	(104,121)
Total current liabilities	171,149	248,944
Long-term liabilities:
Convertible senior notes, net	227,504	226,047
Long-term debt	30,073	0
Long-term deferred revenue	67	334
Long-term operating lease liabilities	6,391	4,306
Long-term contingent consideration	(4,162)	0
Total liabilities	439,346	479,631
Stockholders’ equity:
Common stock, $0.0001 par value—100,000 shares authorized and 39,728 and 33,477 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively	9	9
Additional paid-in capital	1,243,594	1,182,568
Accumulated other comprehensive income	2,467	5,598
Accumulated deficit	(1,111,272)	(976,570)
Total stockholders’ equity	134,798	211,605
Total liabilities and stockholders’ equity	$ 574,144	$ 691,236

About Cardlytics Inc

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.

CEO	Mr. Karim Temsamani
WEBSITE	cardlytics.com
INDUSTRY	Advertising Agencies
EMPLOYEES	473

Cardlytics Inc Frequently Asked Questions

What is the ticker symbol for Cardlytics Inc? What does CDLX stand for in stocks?

CDLX is the stock ticker symbol of Cardlytics Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Cardlytics Inc (CDLX)?

As of Wed May 08 2024, market cap of Cardlytics Inc is 643.11 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CDLX stock?

You can check CDLX's fair value in chart for subscribers.

What is the fair value of CDLX stock?

You can check CDLX's fair value in chart for subscribers. The fair value of Cardlytics Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Cardlytics Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CDLX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Cardlytics Inc a good stock to buy?

The fair value guage provides a quick view whether CDLX is over valued or under valued. Whether Cardlytics Inc is cheap or expensive depends on the assumptions which impact Cardlytics Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CDLX.

What is Cardlytics Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed May 08 2024, CDLX's PE ratio (Price to Earnings) is -4.77 and Price to Sales (PS) ratio is 2.08. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CDLX PE ratio will change depending on the future growth rate expectations of investors.